A double-blind placebo-controlled trial on the effects of 25 mg estradiol implants on the urge syndrome in postmenopausal women

International Urogynecology Journal

Volumn 14, Issue 2, 2003, Pages 78-83

  Rufford, Jane ^a   Hextall, Andrew ^b   Cardozo, Linda ^a   Khullar, Vik ^c  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b WEST HERTFORDSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

'Urge syndrome'; Estrogen

Indexed keywords

ESTRADIOL; GESTAGEN; PLACEBO;

ADULT; ANGINA PECTORIS; ARTICLE; BREAST TENDERNESS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOURETHROGRAPHY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDOMETRIAL DISEASE; ENDOMETRIUM; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; GYNECOLOGY; HUMAN; HYSTERECTOMY; OUTCOMES RESEARCH; PATIENT REFERRAL; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOM; THICKNESS; TREATMENT OUTCOME; URGE INCONTINENCE; URINARY FREQUENCY; URINARY TRACT INFECTION; URINARY URGENCY; URINE VOLUME; UROLOGY; VAGINA BLEEDING; VIDEORECORDING; VISUAL ANALOG SCALE;

EID: 0043029786     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00192-003-1054-3     Document Type: Article

References (22)

1. Diokono AC, Brook BM, Brown MB (1986) Prevalence of urinary incontinence and other urological symptoms in the non-institutionalised elderly. J Urol 136:1022
2. Yarnell J, Voyle G, Richards C, Stephenson T (1981) The prevalence and severity of urinary incontinence in women. J Epidemiol Community Health 35:71-74
3. Cardozo LD, Tapp A, Versi E, Samsioe G, Bonne Erickson P (eds) (1987) The lower urinary tract in peri- and postmenopausal women. In: The urogenital deficiency syndrome. Novo Industri AS, Bagsverd, Denmark, pp 10-17
4. Kondo A, Kato K, Saito M et al (1990) Prevalence of hand washing incontinence in females in comparison with stress and urge incontinence. Neurourol Urodyn 9:330-331
5. Salmon UL, Walter RI, Gast SH (1941) The use of estrogen in the treatment of dysuria and incontinence in postmenopausal women. Am J Obstet Gynaecol 14:23-31
6. Youngblood VH, Tomlin EM, Davis JB (1957) Senile urethritis in women. J Urol 78:150-152
7. Iosif S, Batra S, Ek A, Astedt B (1981) Estrogen receptors in the human female lower urinary tract. Am J Obstet Gynaecol 141:817-820
8. Blakeman PJ, Hilton P, Bulmer JN (1996) Mapping estrogen and progesterone receptors throughout the female lower urinary tract. Neurourol Urodyn 15:324-325
9. Fantl JA, Cardozo LD, McClish DK and the Hormones and Urogenital Therapy committee (1994) Estrogen therapy in the management of incontinence in postmenopausal women. A meta-analysis. First report of the Hormones and Urogenital Therapy Committee. Obstet Gynaecol 83:12-18
10. Walter S, Wolf H, Barlebo H, Jensen K (1978) Urinary incontinence in postmenopausal women treated with estrogens. Urol Int 33:135-143
11. Samsioe G, Jansson I, Mellstrom D, Svanborg A (1980) Urinary incontinence in seventy five year old women: effects of estriol. Acta Obstet Gynecol Scand 93:57
12. Cardozo LD, Rekers H, Tapp A et al (1993) Estriol in the treatment of postmenopausal urgency: a multicentre study. Maturitas 18:47-53
13. Hextall A (2001) The effect of estrogen and the menopause on the female lower urinary tract. MD Thesis, University of London
14. Barlow D (1991) Menopausal care in general practice. Nurs Times 87:49
15. Wilkes H, Meade TW (1991) Hormone replacement therapy in general practice. BMJ 303:416-417
16. Ziel HK, Finkle WD (1975) Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 293:1167-1170
17. Grady D, Gebretsadik T, Kerlikowske K, Emster V, Petitti D (1995) Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol. Feb; 85 (2): 304-313
18. Lethaby A, Farquhar C, Sarkis A, Roberts H, Jepson R, Barlow D (2002) Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding (Cochrane Review). In: The Cochrane Library, Issue 4. Update Software, Oxford
19. Sturdee DW, Wade-Evans T, Paterson ME, Thom M, Studd JW (1978) Relations between bleeding pattern, endometrial histology and estrogen treatment in menopausal women. Br Med J 1:1575-1577
20. Jackson S, Sheperd A, Brookes S, Abrams P (1999) The effect of estrogen supplementation on post-menopausal urinary stress incontinence: double-blind placebo-controlled trial. Br J Obstet Gynaecol 106:711-718
21. Owen EJ, Siddle NC, McGarrigle HT, Pugh MA (1992) 25 mg estradiol implants - the dosage of first choice for subcutaneous estrogen replacement therapy? Br J Obstet Gynaecol 99:671-675
22. Pannay N, Versi E, Savvas M (2000) A comparison of 25 mg and 50 mg estradiol implants in the control of climacteric symptoms following hysterectomy and bilateral salpingo-oophorectomy. Br J Obstet Gynaecol 107:1012-1016